Ómicron: Pfizer, Johnson and Moderna work on a new version of the vaccine – Health
Laboratories Pfizer and Johnson & Johnson (J&J) reported on Monday that they began work on a new version of their anticovid vaccines aimed specifically at the omicron variant, in case the current ones are not effective enough. (See also: Ómicron: what is known about the new ‘variant of concern’ of the coronavirus) “There are still … Read more